Melinta Therapeutics Nearing D-Day...

Melinta Therapeutics Inc. (MLNT), which has gained 59 percent over the last two months, awaits a regulatory catalyst next week.

from RTT - Biotech https://ift.tt/32cGOUF
via IFTTT